Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis
- 1 April 1993
- journal article
- Published by Elsevier in Kidney International
- Vol. 43 (4), 878-884
- https://doi.org/10.1038/ki.1993.123
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Elevated circulating levels of interleukin-6 in patients with chronic renal failureKidney International, 1991
- Establishing the Relationship between Complement Activation and Stimulation of Phagocyte Oxidative Metabolism in Hemodialyzed Patients: A Randomized Prospective StudyNephron, 1991
- Human FcϵRII and IgE-binding factor; Triangular network with IL-2 and IL-4Research in Immunology, 1990
- Human IgE-binding factorsImmunology Today, 1989
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranesKidney International, 1985
- Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole bloodKidney International, 1985
- Complement Activation and Hypersensitivity Reactions to Dialysis MembranesNew England Journal of Medicine, 1984
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976